Amoksycylina

Quick links

Choose a section

Quick links to important sections

Advertisements

Amoksycylina

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Amoksycylina

What is Amoksycylina?

Amoksycylina (amoxicillin) is a broad-spectrum antibiotic belonging to the group of semi-synthetic penicillins. It is a derivative of ampicillin and is classified as a beta-lactam antibiotic due to its chemical structure, which includes a characteristic beta-lactam ring.

Mechanism of Action

The primary function of amoksycylina is to inhibit the synthesis of the bacterial cell wall. It works by binding to specific proteins known as penicillin-binding proteins (PBPs) located inside the bacterial cell wall. This binding prevents the cross-linking of peptidoglycan chains, which are essential for providing the cell wall with mechanical strength and rigidity. Without a stable cell wall, the bacterial cell becomes osmotic unstable, leading to cell lysis and death. Because of this action, amoksycylina is considered a bactericidal antibiotic, meaning it actively kills bacteria rather than merely inhibiting their growth.

Spectrum of Activity

Amoksycylina is effective against a wide range of Gram-positive and Gram-negative microorganisms. Its spectrum of activity includes:

  • Gram-positive bacteria: Such as various species of Streptococcus (including Streptococcus pneumoniae), Enterococcus, and certain strains of Staphylococcus that do not produce penicillinase.
  • Gram-negative bacteria: Including Haemophilus influenzae, Escherichia coli, Proteus mirabilis, and Helicobacter pylori.

Limitations

A significant limitation of amoksycylina is its susceptibility to degradation by enzymes called beta-lactamases. These enzymes are produced by certain resistant bacteria to break down the antibiotic's molecular structure, rendering it ineffective. Consequently, amoksycylina is often used alone only when the infecting bacteria are known or suspected to be susceptible. In cases involving resistant strains, it may be administered in combination with a beta-lactamase inhibitor, such as clavulanic acid, to protect the antibiotic from enzymatic destruction.

Regulatory References

  1. World Health Organization (WHO)
Advertisements

What side effects are possible with Amoksycylina?

Possible Side Effects and Safety Information

The safety profile of Amoksycylina (Amoxicillin) is categorized by official government regulatory authorities, defining potential adverse reactions across various frequency tiers and physiological systems. This information is purely descriptive and non-advisory.


Frequency and System-Organ Classifications

Adverse reactions are classified into frequency tiers based on clinical data documented in regulatory monographs:

  • Common Reactions (ge 1/100 to <1/10): Typically involve the Gastrointestinal System, most notably diarrhea and nausea.
  • Uncommon Reactions (ge 1/1,000 to <1/100): Include vomiting and mild reactions affecting the Skin and Subcutaneous Tissue, such as urticaria (hives) and pruritus (itching).
  • Very Rare Reactions (<1/10,000): Span multiple System-Organ Classes (SOC), including severe hematological effects (e.g., reversible leukopenia, agranulocytosis), hepatobiliary issues (e.g., cholestatic jaundice), and severe neurological effects such as convulsions and hyperkinesia.

Serious Adverse Reactions and Safety Constraints

Serious Adverse Reactions are specifically documented in regulatory labeling. As a penicillin-class medicine, there is a known risk of severe Immediate Hypersensitivity Reactions, including Anaphylaxis. Other serious but very rare reactions include severe cutaneous reactions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), as well as Antibiotic-Associated Colitis.

Population-Specific Safety: The risk of convulsions is heightened in patients with pre-existing renal impairment or those receiving high systemic doses. Official safety constraints dictate that Amoxicillin is strictly contraindicated in patients with a history of severe immediate allergic reactions to any penicillin.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

In the event of a known or suspected overdose of Amoksycylina, immediate medical attention is required, and individuals must contact a poison control center or emergency room at once. This action is mandated by regulatory bodies due to the potential for severe effects.

Overdose manifestations documented in official regulatory sources include primary gastrointestinal disturbances such as nausea, vomiting, and diarrhea. A key physiological finding is Amoxicillin crystalluria, which involves the formation of crystals in the urine and may lead to reversible renal impairment or, in rare cases, renal failure.


Overdose Risk & Manifestations Management & Consideration
Convulsions have been reported with excessively high doses, and this risk is amplified in patients with pre-existing impaired renal function. Management is symptomatic and supportive, as official labeling indicates no specific antidote is known.
The risk of crystalluria is managed by maintaining adequate fluid intake and urinary output to encourage drug clearance. For severe cases of toxicity, haemodialysis is an officially described procedure that can effectively remove the drug from systemic circulation.

This profile is based strictly on the toxicological outcomes and emergency-response statements documented in government-authorized prescribing information, defining when urgent medical help must be sought.

Advertisements

Therapeutic Uses of Amoksycylina

What Amoksycylina Treats: Main Uses and Benefits

Amoksycylina (Amoxicillin) is a penicillin-class medicine relevant in contexts involving certain distressing symptoms where short-term assistance is needed. The medication is commonly used to help manage symptoms associated with infections of the ears, nose, and throat (ENT), lower respiratory tract (such as pneumonia and bronchitis), urinary tract, skin and soft tissue (such as cellulitis and abscesses), and dental conditions.

It is applied across domains where additional symptomatic support is needed and helps address symptom clusters that may become intense or disruptive, such as fever and localized pain, which interfere with daily comfort. This supports the patient during difficult episodes and assists with maintaining functional stability. The drug is also used across conditions involving episodic or fluctuating manifestations and is relevant in preventative contexts, such as using the drug to help prevent infectious endocarditis in high-risk patients.

“Amoksycylina is relevant for managing symptoms that interfere with daily comfort, providing supportive relief when symptoms become noticeable.”


Quick Fact: Relief for Acute Bacterial Symptoms Amoksycylina assists with maintaining functional stability and provides supportive relief when symptoms interfere with routine activities, particularly when symptoms are related to systemic imbalance and inflammatory or irritative states.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

The eligibility profile for Amoksycylina (Amoxicillin) is defined by official regulatory documents that specify groups who are strictly prohibited from use and populations requiring conditional use or special consideration.

Who Must Not Use (Contraindicated)

Use is strictly prohibited (contraindicated) for individuals with a history of a serious hypersensitivity reaction (e.g., anaphylaxis) to amoxicillin or to any other beta-lactam antibacterial drug (including penicillins and cephalosporins). Additionally, regulatory labeling states that Amoksycylina should be avoided if infectious mononucleosis is suspected or confirmed, as this comorbidity is associated with an increased risk of developing a non-allergic skin rash.

Populations Requiring Conditional Use

The medicine is approved for adults and pediatric patients generally older than 12 weeks of age. However, several groups require regulatory caution due to specific physiological factors:

  • Age and Organ Function: Neonates and infants 12 weeks or younger and patients with severe renal impairment require conditional use due to the drug's dependence on renal elimination. Geriatric patients (aged 65 and over) also require caution due to the greater likelihood of decreased kidney function.
  • Reproductive Status: Use during pregnancy is permitted only if clearly needed. Caution is required during lactation as penicillins are excreted into human milk, potentially leading to infant sensitization.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Amoksycylina (Amoxicillin) has documented interaction patterns primarily concerning its renal excretion and pharmacodynamic effects, as specified in regulatory labeling.

Co-administration with Probenecid may increase and prolong the plasma concentrations of Amoxicillin by competitively inhibiting its renal tubular secretion, an exposure-altering pharmacokinetic mechanism. Amoxicillin also affects the renal tubular secretion of Methotrexate, leading to increased Methotrexate plasma concentrations and a subsequent risk of elevated adverse reactions.

Officially documented pharmacodynamic interactions include the risk of abnormal prolongation of prothrombin time (increased INR) when co-administered with Oral Anticoagulants, such as Warfarin, which elevates the general risk of bleeding. Furthermore, concurrent use with Allopurinol is associated with a documented increased incidence of skin rash.

Amoksycylina may also impact the efficacy of other medicines. It may reduce the effectiveness of combined oral contraceptives by interfering with gut flora, which affects estrogen reabsorption. Due to its antibacterial properties, Amoksycylina carries a risk of reduced immunological response when co-administered with live attenuated vaccines, like the oral typhoid vaccine.

In addition, Amoxicillin may lead to false-positive results when testing for glucose in urine using non-enzymatic methods (e.g., CLINITEST®). There are no specific restrictions documented concerning co-administration with food.

Advertisements

Mechanism of Action

Irreversible Blockade of Bacterial Cell Wall Construction

Amoksycylina (Amoxicillin) executes its action by targeting and irreversibly inhibiting crucial bacterial enzymes called Penicillin-Binding Proteins (PBPs), specifically the DD-transpeptidases. By forming a strong, covalent bond with the PBP active site, the drug halts the final step of peptidoglycan cross-linking necessary for building the bacterial cell wall. This molecular interference initiates a cascade resulting in the destruction of the microorganism via cell lysis.


Loss of Osmotic Stability and Bactericidal Effect

The molecular blockade of the PBPs results in a structurally deficient and weak cell wall that cannot maintain the high internal osmotic pressure within the bacterium. This failure in structural integrity causes the cell to rupture (cell lysis) and die rapidly. This mechanism dictates a bactericidal effect—the direct killing of the pathogen—which is the final mechanistic consequence for the targeted microorganism.


Mechanistic Protection Against Resistance (Synergy)

In combination products, a component like Clavulanic acid acts as a suicide inhibitor against bacterial Beta-lactamase enzymes. This auxiliary mechanism prevents the Amoksycylina molecule from being hydrolyzed and destroyed by these bacterial defenses, thereby ensuring the drug remains intact and functional to execute its primary action of inhibiting the Penicillin-Binding Proteins against otherwise resistant bacterial strains.

Advertisements

Dosage and Administration Information

How to Use Amoksycylina

Amoksycylina (Amoxicillin) usage is guided by specific protocols defining the routes, dosing, and administration conditions necessary for its intended purpose. The medicine is primarily available for oral administration via capsules, tablets, and a powder that is reconstituted for oral suspension. Intravenous (IV) or intramuscular (IM) routes are approved for specific formulations in certain clinical settings.

Dosing and Administration Schedules

Administration is generally conducted in divided daily doses to maintain consistent levels of the active substance. Standard regimens specify taking the drug either twice daily (every 12 hours) or three times daily (every 8 hours). Adult dosing ranges from 250 mg to 875 mg per dose, with the total daily dose typically not exceeding 3 g. For prophylactic use, such as preventing endocarditis, a single 2 g dose is generally prescribed.

Feature Guideline
Dosing Frequency Twice or three times daily
Food Intake Can be taken with or without food
Course Duration Typically 5 to 14 days, with specific minimums (e.g., 10 days)

Administration Requirements and Adjustments

Specific formulations require preparation: the powder for oral suspension must be mixed with the required amount of water, and dispersible tablets must be dissolved in liquid prior to consumption. The usage protocol mandates dose adjustments for specific populations. Patients with severe renal impairment require a dose reduction or an extended dosing interval. Pediatric dosing is based on the patient’s body weight in milligrams per kilogram per day (mg/kg/day).

Advertisements

Recent Clinical Evidence

Evidence for Use in Common Infections: Ear and Throat

Research related to common infections like Acute Otitis Media (AOM) and Acute Streptococcal Tonsillitis involves numerous Randomized Controlled Trials (RCTs) and systematic reviews. These studies focused on short-term outcomes related to physical discomfort, the achievement of observed clinical endpoints, and bacterial eradication rates in both children and adults. Findings describe patterns observed in symptom changes, where Amoxicillin was evaluated in comparison to other antibiotic options or placebo. For this type of research, long-term effects are not fully established, and comparative evidence against non-penicillin drugs is often lacking in the literature.


Evidence for Respiratory and Gastrointestinal Conditions

Amoxicillin was studied for Community-Acquired Pneumonia (CAP), with RCTs examining clinical endpoints and the need for subsequent re-treatment in cohorts of children and adults. For Helicobacter Pylori Eradication, Amoxicillin was evaluated in studies as a component of multi-drug combination regimens. Research explored the eradication rates achieved, noting that success was associated with the specific drug combination and local bacterial resistance patterns observed in the studied populations. Data for certain high-risk groups with CAP remain insufficient.


Studies in Special Populations and Research Uncertainty

The use of Amoxicillin for Infective Endocarditis Prophylaxis was observed in high-risk patients, but evidence is limited and largely indirect, relying on drug concentration studies rather than large-scale RCTs measuring IE reduction. Overall research is characterized by limited follow-up durations, meaning long-term outcomes are not fully established. Studies in special populations, such as very young infants, remain insufficient. A major limitation across many indications is the variability across studies, particularly concerning optimal treatment duration and the fact that study outcomes were associated with local resistance patterns in the populations observed.

Key Studies & References

  1. Antibiotics for acute otitis media: a meta-analysis with individual patient data (Cochrane Review)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Amoksycylina (FAQ)

Q: What is Amoksycylina mainly prescribed for?

Amoksycylina is an essential antibiotic used to treat a variety of susceptible bacterial infections. According to regulatory documents, this includes infections of the ear, nose, throat, respiratory tract, and urinary tract. It is also a key component in certain multi-drug regimens used for the eradication of H. pylori bacteria.

Q: What are the most common things people feel when taking Amoksycylina?

Official product information indicates that the most commonly reported reactions involve the gastrointestinal system. These typically include diarrhea and nausea. Other common events noted in regulatory documentation include skin rash.

Q: Can children be given Amoksycylina?

Yes, Amoksycylina is approved for use in pediatric patients, generally those older than 12 weeks of age. Official product information states that the required dosage for children is determined based on their body weight, following a calculation defined in official prescribing information.

Q: Can Amoksycylina be used during pregnancy?

Use of Amoksycylina during pregnancy is described in official regulatory documents as permitted only if the need is clearly established. Caution is also advised during lactation. This is because penicillins, as a class of medicine, are known to be excreted into human milk.

Q: Can Amoksycylina affect blood sugar levels?

Amoxicillin is documented to cause false-positive results when glucose is tested in the urine using certain non-enzymatic methods (which check for sugar). However, official product information does not typically describe the medicine itself as directly altering physiological blood sugar levels in the body.

Q: Does Amoksycylina interact with birth control pills?

Yes, official documents describe a possible interaction with combined oral contraceptives (birth control pills). This medicine may reduce their effectiveness by interfering with the gut flora, which can subsequently affect the body's reabsorption of estrogen.

Q: Can I take Amoksycylina if I have kidney problems?

Regulatory labeling indicates that patients with severe renal impairment require conditional use and special consideration. This is because the drug relies heavily on the kidneys for elimination, often requiring a dosage adjustment or extended time between doses. Official safety constraints note that the risk of adverse effects, such as convulsions, is associated with patients who have renal impairment.

Q: What happens if I stop taking Amoksycylina too soon?

Official regulatory documents advise completing the full prescribed course of medicine. Stopping Amoksycylina prematurely may mean that not all of the infectious bacteria are killed. This can allow the infection to persist or return, and in some cases, it may contribute to the development of bacterial resistance.

Q: What are the official guidelines about driving while taking Amoksycylina?

Official guidance advises patients to exercise caution. Regulatory documents note that in some individuals, the medicine may cause adverse effects such as dizziness or tiredness. Patients should be aware of these potential effects before driving or operating machinery.

Q: Does Amoksycylina need to be taken with food or on an empty stomach?

According to the official dosing and administration schedules, Amoksycylina may be taken with or without food.

Q: Does Amoksycylina lose its effectiveness over time if it is stored improperly?

Official regulatory guidance mandates that the medicine must be protected from moisture and stored below the specified temperature. Improper storage conditions, such as exposure to excessive heat, can potentially reduce the potency of the drug. This loss of effectiveness could then lead to treatment failure.

Q: Does Amoksycylina help with the common cold or the flu?

Amoksycylina is a type of antibiotic, which means it is specifically designed to fight infections caused by bacteria. It is not effective against infections caused by viruses, such as the common cold and the flu.

Q: Can Amoksycylina cause feelings of stomach discomfort?

Yes, common side effects listed in the product information include gastrointestinal symptoms. This includes specific effects like diarrhea and nausea, as well as general stomach upset.

Q: How long does Amoksycylina take to start working?

The medicine begins its action and enters the bloodstream within a few hours of the first dose. However, a noticeable change in the symptoms of the infection is commonly observed within 48 to 72 hours after starting the treatment course.

Q: What is the typical length of time people are prescribed Amoksycylina?

The length of time Amoksycylina is prescribed for can vary. Regulatory documents state that the course duration typically ranges from 5 to 14 days, with the exact duration determined by the specific type and severity of the bacterial infection being treated.

Q: Why does Amoksycylina sometimes cause yeast infections in women?

Amoksycylina can sometimes interfere with the natural balance of organisms in the body. This disruption may lead to an overgrowth of yeast, such as thrush (candidiasis), which is a reported adverse effect noted in official product information.

Q: Is it normal to feel tired while taking Amoksycylina?

While general tiredness and fatigue are often symptoms of the underlying infection itself, side effects such as tiredness or fatigue have also been reported in some individuals taking Amoksycylina, as noted in the patient information leaflets.

Q: Can Amoksycylina cause discoloration on teeth?

Yes, temporary tooth discoloration has been reported as a side effect, particularly in children using the oral suspension. The discoloration, which may appear yellow, brown, or gray, is generally removed by brushing or through cleaning by a dental professional.

Q: Are there any reported interactions between Amoksycylina and herbal supplements?

Official regulatory guidance advises that patients should inform their healthcare provider of all herbal remedies, vitamins, or supplements they are taking. This is recommended due to the limited safety data available on potential unknown interactions with Amoksycylina.

Q: Is there a link between Amoksycylina and certain types of headaches?

Headache has been reported as an adverse reaction in some individuals taking Amoksycylina, according to official regulatory documentation regarding side effects.

Q: Does the time of day affect how Amoksycylina works?

Official administration instructions emphasize the importance of maintaining evenly spaced dosing intervals, such as every 8 or 12 hours. This is done to ensure consistent levels of the active substance in the body. The specific time of day (morning versus evening) is not typically noted as a factor that alters the effectiveness of the drug.

Q: Is Amoksycylina known by any other trade names?

The active ingredient is known internationally as amoxicillin. This substance is sold worldwide under various common trade names, such as Amoxil and Trimox, among many others.

Q: How does Amoksycylina compare to Ampicillin?

Amoksycylina and Ampicillin are structurally similar, both belonging to the aminopenicillin class of medicines. Amoxicillin is known to be better absorbed by the body when taken orally. Pharmacological classifications describe Amoxicillin as having different absorption and tolerability characteristics compared to Ampicillin.

Q: Does Amoksycylina have a standard expiry time from when it is opened?

The shelf life of the dry powder, capsules, and tablets generally lasts up to the printed expiration date on the package if kept unopened. However, the liquid form (oral suspension) has a much shorter in-use period once it has been mixed with water, which is typically 7 to 14 days as stated on the label.

Advertisements

How should Amoksycylina be stored and disposed of?

Official Storage and Disposal Requirements

Storage and disposal instructions for Amoxicillin ( Amoksycylina) are strictly defined by regulatory labeling and vary by formulation. All forms must be kept out of the sight and reach of children.

Formulation Storage Temperature Stability/Handling
Dry Powder, Capsules, Tablets Below 25 C or 30 C (check specific label) Must be protected from moisture and stored in original packaging.
Reconstituted Oral Suspension Refrigerator (2 C to 8 C) Must be discarded after the labeled in-use period (typically 7 to 14 days).

Disposal Rules: Unused or expired medication must not be disposed of via household trash or wastewater (sinks/toilets). Regulatory guidance requires returning the medicine to an authorized take-back program or pharmacy for proper disposal to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Amoksycylina found in:

A-Z Index: